Methyl 2-(2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)acetate

Catalog No. :
ACABXS935
CAS No. :
1985668-80-1
Molecular Formula :
C12H18N2O3
Molecular Weight :
238.29

IUPAC Name:methyl 2-(2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)acetate

Methyl 2-(2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$122.00Login to see priceInquiryInquiry
250mg98%$208.00Login to see priceInquiryInquiry
1g98%$561.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)acetate
IUPAC Namemethyl 2-(2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)acetate
Molecular FormulaC12H18N2O3
Molecular Weight238.29
SMILESO=C(OC)CC1=C(C)N=C(CCCC)NC1=O
InChI KeyQJEKOIUVXLYZFH-UHFFFAOYSA-N
Synonymmethyl 2-(2-butyl-4-hydroxy-6-methylpyrimidin-5-yl)acetate;Methyl 2-(2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)acetate;5-Pyrimidineacetic acid, 2-butyl-1,6-dihydro-4-methyl-6-oxo-, methyl ester
CAS No.1985668-80-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACABXS935 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACABXS935 route product structure diagram
    ACABXS9351985668-80-1
Inquiry

2. ACABXS935 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACABXS935 route product structure diagram
    ACABXS9351985668-80-1
Inquiry

Comments (0)